Events

Workshop on Tele-Healthcare and 5G
OCT
Fri
22
09:00 - 13:00

This was 3 years ago

Location

Online

Programmes
Health Digital, Industry & Space

The aim of the workshop is to present and discuss upcoming opportunities in the healthcare sector enabled by technology developments in 5G. More specifically, it will deal with:

  • Tele-health Applications addressed by the 5G Public Private Partnership
  • Tele-health solutions for Ambulance Care (Panel Discussion)
  • Business Models for 5G Tele-health (Panel Discussion)

 

This workshop is organised by the 5G-TOURS and 5G HEART projects, that are funded under Horizon 2020 (5G PPP programme). 5G-TOURS' vision is to improve the life in the city for the citizens and tourists. 5G-HEART focuses on pilots in healthcare, transport and aquaculture.

More info and registration on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.